Ledong Wan

1.5k total citations · 1 hit paper
17 papers, 1.1k citations indexed

About

Ledong Wan is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Ledong Wan has authored 17 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Ledong Wan's work include RNA modifications and cancer (9 papers), RNA Research and Splicing (6 papers) and Cancer-related molecular mechanisms research (4 papers). Ledong Wan is often cited by papers focused on RNA modifications and cancer (9 papers), RNA Research and Splicing (6 papers) and Cancer-related molecular mechanisms research (4 papers). Ledong Wan collaborates with scholars based in China, United States and France. Ledong Wan's co-authors include Maode Lai, Enping Xu, Hui Cao, Hong Liu, Honghe Zhang, Jianlu Kong, Yihua Wu, Wenjie Sun, Chen Li and Shuo Wang and has published in prestigious journals such as Nature Genetics, Cancer Cell and Cancer Research.

In The Last Decade

Ledong Wan

17 papers receiving 1.1k citations

Hit Papers

Chronic stress increases metastasis via neutrophil-mediat... 2024 2026 2025 2024 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ledong Wan China 13 680 438 263 147 119 17 1.1k
Jiaqiang Dong China 17 780 1.1× 427 1.0× 257 1.0× 97 0.7× 97 0.8× 30 1.2k
Joan Lewis-Wambi United States 20 631 0.9× 323 0.7× 424 1.6× 141 1.0× 129 1.1× 31 1.3k
Sanchita Rauth United States 18 558 0.8× 204 0.5× 378 1.4× 171 1.2× 118 1.0× 36 962
Katherine Drews‐Elger United States 13 514 0.8× 235 0.5× 359 1.4× 159 1.1× 71 0.6× 20 1.0k
Laurent Lessard Canada 17 811 1.2× 528 1.2× 359 1.4× 225 1.5× 259 2.2× 25 1.3k
Zhilin Zou China 10 560 0.8× 222 0.5× 227 0.9× 77 0.5× 133 1.1× 24 901
Qiao‐Li Lv China 21 767 1.1× 552 1.3× 124 0.5× 93 0.6× 95 0.8× 64 1.1k
Akira Morimiya United States 11 628 0.9× 343 0.8× 504 1.9× 97 0.7× 159 1.3× 16 1.1k
Xiaohui Pan China 16 517 0.8× 306 0.7× 217 0.8× 188 1.3× 109 0.9× 27 853
Junjie Piao China 20 676 1.0× 265 0.6× 208 0.8× 60 0.4× 153 1.3× 40 956

Countries citing papers authored by Ledong Wan

Since Specialization
Citations

This map shows the geographic impact of Ledong Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ledong Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ledong Wan more than expected).

Fields of papers citing papers by Ledong Wan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ledong Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ledong Wan. The network helps show where Ledong Wan may publish in the future.

Co-authorship network of co-authors of Ledong Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Ledong Wan. A scholar is included among the top collaborators of Ledong Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ledong Wan. Ledong Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Maia-Silva, Diogo, Damianos Skopelitis, Yuan Gao, et al.. (2024). Interaction between MED12 and ΔNp63 activates basal identity in pancreatic ductal adenocarcinoma. Nature Genetics. 56(7). 1377–1385. 6 indexed citations
2.
Wan, Ledong, et al.. (2024). Screening Splice-Switching Antisense Oligonucleotides in Pancreas-Cancer Organoids. Nucleic Acid Therapeutics. 34(4). 188–198. 7 indexed citations
3.
He, Xue‐Yan, David Ng, Evdokia Michalopoulou, et al.. (2024). Chronic stress increases metastasis via neutrophil-mediated changes to the microenvironment. Cancer Cell. 42(3). 474–486.e12. 121 indexed citations breakdown →
4.
Wan, Ledong, Kuan‐Ting Lin, Mohammad Alinoor Rahman, et al.. (2023). Splicing Factor SRSF1 Promotes Pancreatitis and KRASG12D-Mediated Pancreatic Cancer. Cancer Discovery. 13(7). 1678–1695. 37 indexed citations
5.
He, Xue‐Yan, David Ng, Yuan Gao, et al.. (2023). Abstract 62: Untangling the connection between stress and metastatic breast cancer. Cancer Research. 83(7_Supplement). 62–62. 1 indexed citations
6.
Wan, Ledong, et al.. (2022). SR Splicing Factors Promote Cancer via Multiple Regulatory Mechanisms. Genes. 13(9). 1659–1659. 7 indexed citations
7.
Zhu, Yimin, Hanlin Lu, Dandan Zhang, et al.. (2018). Integrated analyses of multi-omics reveal global patterns of methylation and hydroxymethylation and screen the tumor suppressive roles of HADHB in colorectal cancer. Clinical Epigenetics. 10(1). 30–30. 33 indexed citations
8.
Wan, Ledong, Wenying Yu, Enhui Shen, et al.. (2017). SRSF6-regulated alternative splicing that promotes tumour progression offers a therapy target for colorectal cancer. Gut. 68(1). 118–129. 134 indexed citations
9.
Kong, Jianlu, Wenjie Sun, Chen Li, et al.. (2016). Long non-coding RNA LINC01133 inhibits epithelial–mesenchymal transition and metastasis in colorectal cancer by interacting with SRSF6. Cancer Letters. 380(2). 476–484. 155 indexed citations
10.
Wan, Ledong, Jianlu Kong, Jinlong Tang, et al.. (2016). HOTAIRM1 as a potential biomarker for diagnosis of colorectal cancer functions the role in the tumour suppressor. Journal of Cellular and Molecular Medicine. 20(11). 2036–2044. 69 indexed citations
11.
Cao, Hui, Jing Zhang, Hong Liu, et al.. (2016). IL-13/STAT6 signaling plays a critical role in the epithelial-mesenchymal transition of colorectal cancer cells. Oncotarget. 7(38). 61183–61198. 76 indexed citations
12.
Cao, Hui, Enping Xu, Hong Liu, Ledong Wan, & Maode Lai. (2015). Epithelial–mesenchymal transition in colorectal cancer metastasis: A system review. Pathology - Research and Practice. 211(8). 557–569. 295 indexed citations
13.
Yu, Dan, Zhenli Li, Meifu Gan, et al.. (2015). Decreased expression of dual specificity phosphatase 22 in colorectal cancer and its potential prognostic relevance for stage IV CRC patients. Tumor Biology. 36(11). 8531–8535. 18 indexed citations
14.
Zhou, Dan, Zhenli Li, Dan Yu, et al.. (2015). Polymorphisms involving gain or loss of CpG sites are significantly enriched in trait-associated SNPs. Oncotarget. 6(37). 39995–40004. 27 indexed citations
15.
Han, Chun, Ledong Wan, Hongbin Ji, et al.. (2014). Synthesis and evaluation of 2-anilinopyrimidines bearing 3-aminopropamides as potential epidermal growth factor receptor inhibitors. European Journal of Medicinal Chemistry. 77. 75–83. 16 indexed citations
16.
Han, Chun, Zhangjian Huang, Chao Zheng, et al.. (2013). Nitric oxide donating anilinopyrimidines: Synthesis and biological evaluation as EGFR inhibitors. European Journal of Medicinal Chemistry. 66. 82–90. 16 indexed citations
17.
Han, Chun, Zhangjian Huang, Chao Zheng, et al.. (2013). Novel Hybrids of (Phenylsulfonyl)furoxan and Anilinopyrimidine as Potent and Selective Epidermal Growth Factor Receptor Inhibitors for Intervention of Non-Small-Cell Lung Cancer. Journal of Medicinal Chemistry. 56(11). 4738–4748. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026